Risk-factors for acquisition of extended-spectrum β-lactamase-producing Escherichia coli among hospitalised patients

This publication has 20 references indexed in Scilit:

• Outcome of Cephalosporin Treatment for Serious Infections Due to Apparently Susceptible Organisms Producing Extended-Spectrum β-Lactamases: Implications for the Clinical Microbiology Laboratory
  Journal of Clinical Microbiology, 2001
• Multiple Antibiotic–Resistant Klebsiella and Escherichia coli in Nursing Homes
  JAMA, 1999
• Epidemiology and Successful Control of a Large Outbreak Due to Klebsiella pneumoniae Producing ExtendedSpectrum β-Lactamases
  Antimicrobial Agents and Chemotherapy, 1998
• Ceftazidime-Resistant Klebsiella pneumoniae and Escherichia coli Bloodstream Infection: A Case-Control and Molecular Epidemiologic Investigation
  The Journal of Infectious Diseases, 1996
• Outbreak of Multiply Resistant Enterobacteriaceae in an Intensive Care Unit: Epidemiology and Risk Factors for Acquisition
  Clinical Infectious Diseases, 1996
• Nosocomial Outbreak of Klebsiella Infection Resistant to Late-Generation Cephalosporins
  Annals of Internal Medicine, 1993
• Outbreak of nosocomial infections due toKlebsiella pneumoniae producing SHV-4 beta-lactamase
  European Journal of Clinical Microbiology & Infectious Diseases, 1990
• Klebsiella pneumoniae and Other Enterobacteriaceae Producing Novel Plasmid-Mediated -Lactamases Markedly Active Against Third-Generation Cephalosporins: Epidemiologic Studies
  Clinical Infectious Diseases, 1988
• Novel R-factor borne β-lactamase of Escherichia coli confering resistance to cephalosporins
  Infection, 1987
• Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens
  Infection, 1983